by TractManager | Feb 8, 2024 | Emerging Technology Report
The Evoque Tricuspid Valve Replacement System (Edwards Lifesciences Corp.) is indicated for the improvement of health status in patients with symptomatic severe tricuspid regurgitation despite optimal medical therapy, for whom tricuspid valve replacement is deemed...
by TractManager | Feb 8, 2024 | Emerging Technology Report
Darvadstrocel is an injectable allogeneic, expanded, adipose-derived mesenchymal stem cell product. It is proposed as an adjunct to standard medical care for treatment-refractory complex perianal fistula in adults with Crohn disease. Darvadstrocel is in phase III...
by TractManager | Feb 2, 2024 | Emerging Technology Report
The Farapulse Pulsed Field Ablation System (Boston Scientific Corporation) is indicated for the isolation of pulmonary veins in the treatment of drug-refractory, recurrent, symptomatic paroxysmal atrial fibrillation.
Recent Comments